Anika Therapeutics Inc (ANIK): Next-Year EPS Estimate 229.17%
As of 2026-06-04, Anika Therapeutics Inc (ANIK) has a next-year EPS growth estimate of 229.17%.
On 2026-04-30, analyst consensus for ANIK's next-year EPS growth shifted from 162.50% to 229.17% — a positive change of 66.67 percentage points. The revised estimate has been sustained across 26 subsequent trading sessions. Current-year growth is projected at -209.09%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- EPS growth next year
- 229.17%
- EPS growth this year
- -209.09%
- EPS next quarter (est)
- -$0.08
- Last price
- $14.79
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-04 | 229.17% | -209.09% | -$0.08 | $14.79 |
| 2026-06-03 | 229.17% | -209.09% | -$0.08 | $14.41 |
| 2026-06-02 | 229.17% | -209.09% | -$0.08 | $14.38 |
| 2026-06-01 | 229.17% | -209.09% | -$0.08 | $14.63 |
| 2026-05-31 | 229.17% | -209.09% | -$0.08 | $14.53 |
| 2026-05-28 | 229.17% | -209.09% | -$0.08 | $14.90 |
| 2026-05-27 | 229.17% | -209.09% | -$0.08 | $14.81 |
| 2026-05-26 | 229.17% | -209.09% | -$0.08 | $14.89 |
| 2026-05-25 | 229.17% | -209.09% | -$0.08 | $14.88 |
| 2026-05-24 | 229.17% | -209.09% | -$0.08 | $14.88 |
| 2026-05-21 | 229.17% | -209.09% | -$0.08 | $15.02 |
| 2026-05-20 | 229.17% | -209.09% | -$0.08 | $15.14 |
| 2026-05-19 | 229.17% | -209.09% | -$0.08 | $14.82 |
| 2026-05-18 | 229.17% | -209.09% | -$0.08 | $14.95 |
| 2026-05-17 | 229.17% | -209.09% | -$0.08 | $14.91 |
| 2026-05-14 | 229.17% | -209.09% | -$0.08 | $15.34 |
| 2026-05-13 | 229.17% | -209.09% | -$0.08 | $14.70 |
| 2026-05-12 | 229.17% | -209.09% | -$0.08 | $14.68 |
| 2026-05-11 | 229.17% | -209.09% | -$0.08 | $14.54 |
| 2026-05-10 | 229.17% | -209.09% | -$0.08 | $14.77 |
| 2026-05-07 | 229.17% | -209.09% | -$0.08 | $15.14 |
| 2026-05-06 | 229.17% | -209.09% | -$0.08 | $15.12 |
| 2026-05-05 | 229.17% | -209.09% | -$0.08 | $14.95 |
| 2026-05-04 | 229.17% | -209.09% | -$0.08 | $14.55 |
| 2026-05-03 | 229.17% | -209.09% | -$0.08 | $14.85 |
| 2026-04-30 | 229.17% | -209.09% | -$0.08 | $12.45 |
| 2026-04-29 | 162.50% | -281.82% | -$0.06 | $12.39 |
| 2026-04-28 | 4600.00% | -104.55% | -$0.07 | $15.26 |
| 2026-04-27 | 4600.00% | -104.55% | -$0.07 | $15.85 |
| 2026-04-26 | 4600.00% | -104.55% | -$0.07 | $15.37 |
Recent News
Screen Performance
Aggregate stats across all 1761 tickers our top-EPS-revision screen has flagged over the past 64 days.
- Median return since detection
- +5.1%
- % of tickers in the green
- 62%
- Median return on winners
- +17.5%
- Large revisions captured
- 746
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Anika Therapeutics Inc's next-year EPS growth estimate?▾
As of 2026-06-04, Anika Therapeutics Inc (ANIK) has a next-year EPS growth estimate of 229.17%, based on analyst consensus.
When was the latest EPS estimate revision for ANIK?▾
The most recent revision occurred on 2026-04-30, when analysts adjusted the next-year EPS growth estimate from 162.50% to 229.17%.
What sector and industry does Anika Therapeutics Inc belong to?▾
Anika Therapeutics Inc operates in the Healthcare sector, specifically the Drug Manufacturers - Specialty & Generic industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ANIK appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Anika Therapeutics Inc (ANIK) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports